177 related articles for article (PubMed ID: 35693303)
1. Pediatric Critical Illness Score, Clinical Characteristics and Comprehensive Treatment of Children with Severe Mycoplasma Pneumoniae Pneumonia.
Fang C; Mao Y; Jiang M; Yin W
Front Surg; 2022; 9():897550. PubMed ID: 35693303
[TBL] [Abstract][Full Text] [Related]
2. Prediction Model for Severe Mycoplasma pneumoniae Pneumonia in Pediatric Patients by Admission Laboratory Indicators.
Chang Q; Chen HL; Wu NS; Gao YM; Yu R; Zhu WM
J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35903920
[TBL] [Abstract][Full Text] [Related]
3. D-dimer: The Risk Factor of Children's Severe Mycoplasma Pneumoniae Pneumonia.
Qiu J; Ge J; Cao L
Front Pediatr; 2022; 10():828437. PubMed ID: 35498793
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the Clinical Efficacy and Safety of High- and Low-dose Methylprednisolone in the Treatment of Children With Severe Mycoplasma Pneumoniae Pneumonia.
Sun LL; Ye C; Zhou YL; Zuo SR; Deng ZZ; Wang CJ
Pediatr Infect Dis J; 2020 Mar; 39(3):177-183. PubMed ID: 31738328
[TBL] [Abstract][Full Text] [Related]
5. A prediction study of IL-18 and IFN-γ in glucocorticoid treatment response in infants and young children with severe
Zhu R; Mao S; Shi W; Wu L; Zhang J
Transl Pediatr; 2022 May; 11(5):738-747. PubMed ID: 35685073
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Thrombotic Complication of Mycoplasma pneumoniae Pneumonia in Chinese Children: Clinical Feature and Risk Factor Analysis.
Yu Y; Jin X; Zhang X; Shen Y
Pediatr Infect Dis J; 2024 Jun; 43(6):505-510. PubMed ID: 38359345
[TBL] [Abstract][Full Text] [Related]
7. Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe mycoplasma pneumoniae pneumonia.
Wu X; Lu W; Wang T; Xiao A; Guo X; Xu Y; Li S; Liu X; Zeng H; He S; Zhang X
BMC Infect Dis; 2023 Oct; 23(1):661. PubMed ID: 37798699
[TBL] [Abstract][Full Text] [Related]
8. Serum cytokine profiling reveals different immune response patterns during general and severe
Zhang Z; Dou H; Tu P; Shi D; Wei R; Wan R; Jia C; Ning L; Wang D; Li J; Dong Y; Xin D; Xu B
Front Immunol; 2022; 13():1088725. PubMed ID: 36618370
[No Abstract] [Full Text] [Related]
9. The Level of D-Dimer Is Positively Correlated With the Severity of
Zheng Y; Hua L; Zhao Q; Li M; Huang M; Zhou Y; Wang Y; Chen Z; Zhang Y
Front Cell Infect Microbiol; 2021; 11():687391. PubMed ID: 34336714
[TBL] [Abstract][Full Text] [Related]
10. Study on the Correlation Between the Expression of NF-Ƙb in the Alveolar Lavage Fluid of Children with Severe Mycoplasma Pneumoniae Pneumonia, Its Clinical Characteristics, and Cellular Immunity.
Ding X; Li S; Liu X; Zhan X; Wang Z; Wang M; Wu G
Infect Drug Resist; 2024; 17():2469-2484. PubMed ID: 38915319
[TBL] [Abstract][Full Text] [Related]
11. Effect of azithromycin combined with ambroxol in children with Mycoplasma pneumoniae pneumonia.
Ni Y; Fang M; Jiang J; Lou Q; Wu L; Liu Z
Am J Transl Res; 2023; 15(1):202-212. PubMed ID: 36777866
[TBL] [Abstract][Full Text] [Related]
12. Epidemic characteristics of
Lv YT; Sun XJ; Chen Y; Ruan T; Xu GP; Huang JA
Ann Transl Med; 2022 Oct; 10(20):1123. PubMed ID: 36388772
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children.
Zhang X; Sun R; Jia W; Li P; Song C
Infect Dis Ther; 2024 Feb; 13(2):329-343. PubMed ID: 38265626
[TBL] [Abstract][Full Text] [Related]
14. A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children.
Zhang X; Sun R; Jia W; Li P; Song C
Sci Rep; 2024 Apr; 14(1):8260. PubMed ID: 38589453
[TBL] [Abstract][Full Text] [Related]
15. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
16. Changes in coagulation markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for Mycoplasma severity.
Li YT; Zhang J; Wang MZ; Ma YM; Zhi K; Dai FL; Li SJ
Ital J Pediatr; 2023 Oct; 49(1):143. PubMed ID: 37858230
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A deficiency is associated with severe
Xing Y; Sheng K; Xiao X; Li J; Wei H; Liu L; Zhou W; Tong X
Ann Transl Med; 2020 Feb; 8(4):120. PubMed ID: 32175413
[TBL] [Abstract][Full Text] [Related]
18. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children.
Zheng B; Zhao J; Cao L
BMC Infect Dis; 2020 Jun; 20(1):391. PubMed ID: 32487034
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between Mycoplasma pneumoniae DNA replication level and disease severity in children with severe Mycoplasma pneumoniae pneumonia].
Fang KN; Wang J; Ni JW
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Sep; 21(9):876-880. PubMed ID: 31506145
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study.
Luo XQ; Luo J; Wang CJ; Luo ZX; Tian DY; Xie XH
Pediatr Pulmonol; 2023 Oct; 58(10):2815-2822. PubMed ID: 37431970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
